Eos Management L.P. Buys 926 Shares of Danaher Co. (NYSE:DHR)

Eos Management L.P. raised its stake in shares of Danaher Co. (NYSE:DHR) by 4.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,978 shares of the conglomerate’s stock after acquiring an additional 926 shares during the period. Danaher makes up 2.1% of Eos Management L.P.’s holdings, making the stock its 10th biggest holding. Eos Management L.P.’s holdings in Danaher were worth $6,110,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in DHR. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher in the 2nd quarter valued at about $25,000. nVerses Capital LLC acquired a new position in shares of Danaher in the second quarter valued at approximately $25,000. MFA Wealth Advisors LLC purchased a new stake in Danaher during the 2nd quarter worth approximately $51,000. Financial Connections Group Inc. purchased a new position in Danaher in the 2nd quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in shares of Danaher in the first quarter worth $55,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of Danaher stock opened at $245.39 on Friday. The stock has a market capitalization of $177.24 billion, a price-to-earnings ratio of 46.83, a PEG ratio of 4.55 and a beta of 0.85. The firm’s fifty day simple moving average is $264.89 and its 200-day simple moving average is $260.71. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 12 month low of $192.35 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the prior year, the company earned $2.02 earnings per share. The business’s revenue was up 3.1% compared to the same quarter last year. As a group, equities analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s payout ratio is currently 20.61%.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on DHR. Evercore ISI increased their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. UBS Group decreased their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Wells Fargo & Company started coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price on the stock. Stifel Nicolaus boosted their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Finally, Barclays reduced their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.